Spotfire®Tailored Workflows and Curated Analytics Provide Visibility Across Relevant Data Domains for Medical Monitors
What: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, recently announced the launch of PerkinElmer Signals™ Medical Review. This new cloud-based analytics and visualization solution provides medical monitors in clinical development with smarter insights to quickly detect safety signals and reduce time to submission.
Why: The growing volume and complexity of clinical trial data is putting medical monitors at risk of missing safety signals. In addition, manual tracking processes could result in delayed or rejected submissions, market withdrawal, and compromise the safety of clinical trial subjects.
“In today’s clinical development setting, medical monitors have to hunt for specific subjects of interest, track sets of information, and invest time in applying generic analytics capabilities to their day-to-day tasks,” said David Wang, Vice President and General Manager, Informatics, PerkinElmer. “PerkinElmer Signals Medical Review provides a powerful combination of customized, role-based workflows and analytics to help medical monitors find the data they need. With the solution, users can quickly review and analyze all the clinical data, helping to ensure data quality and subject safety.”
How It Works: PerkinElmer Signals Medical Review aggregates clinical and laboratory data and provides medical monitors with visual analytics most applicable to their roles via tailor-built workflows. This innovative approach to getting timely, critical information to the appropriate recipients is combined with advanced analytics from TIBCO Spotfire® software. With the platform, reviewers can quickly respond to questions, uncover trends and outliers across Clinical Data Interchange Standards Consortium (CDISC) domains and identify risks from a single interface in near real-time.
Key Features: The solution’s secure cloud-based infrastructure is user-friendly and allows for faster setup of new studies. Its intuitive interface provides 360-degree visibility with built-in patient profiles, configurable alerts, and medical review status reporting and tracking.
More: PerkinElmer Signals Medical Review is the latest addition to the PerkinElmer Signals™ platform, which aims to help scientists navigate the increasing complexities of big data to accelerate research and drug development decisions. For more information on PerkinElmer Signals Medical Review, please visit www.perkinelmer.com/smr.
PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics and discovery and analytical solutions markets. Our innovative detection, imaging, informatics, and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1B in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. For more information, visit www.perkinelmer.com.